208 related articles for article (PubMed ID: 37724378)
21. [Mechanism of action of tezepelumab (TEZSPIRE
Niu M; Yabuta T; Makita N
Nihon Yakurigaku Zasshi; 2024; 159(1):53-60. PubMed ID: 38171840
[TBL] [Abstract][Full Text] [Related]
22. Thymic Stromal Lymphopoietin Isoforms, Inflammatory Disorders, and Cancer.
Varricchi G; Pecoraro A; Marone G; Criscuolo G; Spadaro G; Genovese A; Marone G
Front Immunol; 2018; 9():1595. PubMed ID: 30057581
[TBL] [Abstract][Full Text] [Related]
23. Thymic stromal lymphopoietin plays divergent roles in murine models of atopic and nonatopic airway inflammation.
Yadava K; Massacand J; Mosconi I; Nicod LP; Harris NL; Marsland BJ
Allergy; 2014 Oct; 69(10):1333-42. PubMed ID: 24961817
[TBL] [Abstract][Full Text] [Related]
24. Tezepelumab in Adults with Uncontrolled Asthma.
Corren J; Parnes JR; Wang L; Mo M; Roseti SL; Griffiths JM; van der Merwe R
N Engl J Med; 2017 Sep; 377(10):936-946. PubMed ID: 28877011
[TBL] [Abstract][Full Text] [Related]
25. Tezepelumab: First Approval.
Hoy SM
Drugs; 2022 Mar; 82(4):461-468. PubMed ID: 35184265
[TBL] [Abstract][Full Text] [Related]
26. Thymic stromal lymphopoietin: a central regulator of allergic asthma.
Watson B; Gauvreau GM
Expert Opin Ther Targets; 2014 Jul; 18(7):771-85. PubMed ID: 24930783
[TBL] [Abstract][Full Text] [Related]
27. Development of an inhaled anti-TSLP therapy for asthma.
O'Byrne PM; Panettieri RA; Taube C; Brindicci C; Fleming M; Altman P
Pulm Pharmacol Ther; 2023 Feb; 78():102184. PubMed ID: 36535465
[TBL] [Abstract][Full Text] [Related]
28. Blockade of thymic stromal lymphopoietin and CRTH2 attenuates airway inflammation in a murine model of allergic asthma.
Lee HY; Lee HY; Hur J; Kang HS; Choi JY; Rhee CK; Kang JY; Kim YK; Lee SY
Korean J Intern Med; 2020 May; 35(3):619-629. PubMed ID: 32183504
[TBL] [Abstract][Full Text] [Related]
29. [Tezepelumab: a new option for the treatment of severe asthma].
Maldonado-Ríos VA; Ardila-Herrera JC; Galicia-Sánchez LM; Celis-Preciado CA
Rev Med Inst Mex Seguro Soc; 2023 Nov; 61(6):841-848. PubMed ID: 37995367
[TBL] [Abstract][Full Text] [Related]
30. Successful Treatment of Eosinophilic Chronic Rhinosinusitis and Secretory Otitis Media in Refractory Asthma With Thymic Stromal Lymphopoietin (TSLP) Receptor Monoclonal Antibody.
Kawashima K; Matsuno O; Okuno M; Kawabe T; Hanada Y
Cureus; 2023 Oct; 15(10):e47798. PubMed ID: 38022039
[TBL] [Abstract][Full Text] [Related]
31. The last step to achieve barrier damage control.
Baglivo I; Colantuono S; Lumaca A; Papa A; Gasbarrini A; Caruso C
Front Immunol; 2024; 15():1354556. PubMed ID: 38415254
[TBL] [Abstract][Full Text] [Related]
32. Thymic stromal lymphopoietin (TSLP) and Toluene-diisocyanate-induced airway inflammation: Alleviation by TSLP neutralizing antibody.
Yu G; Zhang Y; Wang X; Sai L; Bo C; Yeo AJ; Lavin MF; Peng C; Jia Q; Shao H
Toxicol Lett; 2019 Dec; 317():59-67. PubMed ID: 31577921
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic and Pharmacodynamic Modeling of Tezepelumab to Guide Phase 3 Dose Selection for Patients With Severe Asthma.
Ly N; Zheng Y; Griffiths JM; van der Merwe R; Agoram B; Parnes JR; Roskos L
J Clin Pharmacol; 2021 Jul; 61(7):901-912. PubMed ID: 33368307
[TBL] [Abstract][Full Text] [Related]
34. Thymic stromal lymphopoietin promotes lung inflammation through activation of dendritic cells.
Li YL; Li HJ; Ji F; Zhang X; Wang R; Hao JQ; Bi WX; Dong L
J Asthma; 2010 Mar; 47(2):117-23. PubMed ID: 20170316
[TBL] [Abstract][Full Text] [Related]
35. Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD.
Calderon AA; Dimond C; Choy DF; Pappu R; Grimbaldeston MA; Mohan D; Chung KF
Eur Respir Rev; 2023 Mar; 32(167):. PubMed ID: 36697211
[TBL] [Abstract][Full Text] [Related]
36. [Tezepelumab (Tezspire®) : new biological treatment of severe asthma].
Schleich F; Sabbe M; Moermans C; Louis R
Rev Med Liege; 2024 Jan; 79(1):60-64. PubMed ID: 38223972
[TBL] [Abstract][Full Text] [Related]
37. Severe Asthmatic Responses: The Impact of TSLP.
Theofani E; Tsitsopoulou A; Morianos I; Semitekolou M
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108740
[TBL] [Abstract][Full Text] [Related]
38. Thymic Stromal Lymphopoietin (TSLP), Its Isoforms and the Interplay with the Epithelium in Allergy and Asthma.
Smolinska S; Antolín-Amérigo D; Popescu FD; Jutel M
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628907
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and Potential Positioning of Tezepelumab in the Treatment of Severe Asthma.
Plaza V; Cañete C; Domingo C; Martínez Rivera C; Muñoz X
Open Respir Arch; 2023; 5(2):100231. PubMed ID: 37496871
[TBL] [Abstract][Full Text] [Related]
40. Sounding the alarmins-The role of alarmin cytokines in asthma.
Gauvreau GM; Bergeron C; Boulet LP; Cockcroft DW; Côté A; Davis BE; Leigh R; Myers I; O'Byrne PM; Sehmi R
Allergy; 2023 Feb; 78(2):402-417. PubMed ID: 36463491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
